Esperion Therapeutics
Marc Dervishian has a diverse work experience, starting with their current role as Vice President of Sales at Esperion. Prior to this, they worked at Merck for several years in various roles. These include being the Director of Commercial Operations for Merck Vaccines, where they managed commercial operations for the vaccines division. Marc also served as the National Sales Director for CV/Respiratory/Contract Sales and as the Director of Commercial Operations for the Atlanta region. In their earlier years at Merck, they were responsible for managing the Southeast Managed Care business, overseeing a team of account executives and handling a portfolio of products worth over $2 billion in sales.
Marc Dervishian obtained a Bachelor of Science degree in Biology from Ursinus College, which they attended from 1984 to 1988. Marc later pursued a Master of Business Administration (MBA) degree with a focus on Marketing/Finance at Villanova University from 1988 to 1990. Additionally, Marc Dervishian completed an Executive Education program in Marketing Strategy at The Wharton School, although the specific time frame for this achievement is not provided.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.